Since our founding, we have understood that by operating in a sustainable manner, benefits accrue to our employees, investors, environment, communities, and the patients we seek to serve. Ultimately, patients are at the center of our corporate citizenship efforts, and all else at Adroit Clinicals. We are stewards of novel compounds with the potential to increase quality of life and life expectancy. Today, our lead programs are in rare, life-threatening diseases.
Our work to bring forward innovative medicines for areas of severe unmet need is, at its core, a driver of positive social impact. At Adroit Clinicals, we strive to be a leader in the way we incorporate a patient focus across functions.